identifying and treating high-risk/mrd positive newly diagnosed multiple myeloma
Published 2 years ago • 115 plays • Length 13:20Download video MP4
Download video MP3
Similar videos
-
4:24
managing high-risk/mrd positive and standard-risk/mrd myeloma
-
29:08
newly diagnosed multiple myeloma, response, bone health, renal health, mrd, survivorship care
-
47:18
diagnosis and risk assessment in multiple myeloma
-
5:20
follow-up and mrd testing in high-risk myeloma
-
1:27
maintenance therapy and mrd in myeloma
-
1:11:05
the utility of mrd testing for myeloma patient treatment and outcomes
-
1:33:39
the relevance of mrd assessment in the clinical management of multiple myeloma (mm) patients
-
3:21
is there a new highly sensitive blood test to detect minimal residual disease?
-
23:32
approaching mrd in multiple myeloma
-
2:10
microenvironment features associated with mrd negativity in patients with myeloma treated with dkrd
-
1:12:05
a practical approach to mrd: testing with clonoseq
-
21:35
treatment options for newly diagnosed multiple myeloma and management of bone disease: imw 2017
-
45:28
faqs on high-risk disease
-
21:08
mrd evaluation in myeloma: the future is here
-
1:02:07
is mrd negativity the goal of myeloma treatment?
-
19:41
multiple myeloma: minimal residual disease
-
4:03
krd versus vrd in patients with newly diagnosed multiple myeloma
-
4:01
if a myeloma patient has mrd-negative status, does that mean that patient is cured?